Cargando…
Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study
INTRODUCTION: Diquafosol is a P2Y(2) receptor agonist that has been shown to be effective in the treatment of dry eye disease (DED) in short-term studies; however, its long-term safety and effectiveness have not been evaluated in a real-world setting. METHODS: This prospective, multicentre, open-lab...
Autores principales: | Ohashi, Yuichi, Munesue, Masahiro, Shimazaki, Jun, Takamura, Etsuko, Yokoi, Norihiko, Watanabe, Hitoshi, Nomura, Akio, Shimada, Fumiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004437/ https://www.ncbi.nlm.nih.gov/pubmed/31834617 http://dx.doi.org/10.1007/s12325-019-01188-x |
Ejemplares similares
-
Real-world assessment of diquafosol in dry eye patients with risk factors such as contact lens, meibomian gland dysfunction, and conjunctivochalasis: subgroup analysis from a prospective observational study
por: Yamaguchi, Masahiko, et al.
Publicado: (2015) -
A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
por: Takamura, Etsuko, et al.
Publicado: (2012) -
Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study
por: Miyake, Kensaku, et al.
Publicado: (2017) -
Adherence to Eye Drops Usage in Dry Eye Patients and Reasons for Non-Compliance: A Web-Based Survey
por: Uchino, Miki, et al.
Publicado: (2022) -
Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh, Shizuka
Publicado: (2015)